Multi-Center, Multi-National, Open Label, Safety study of Etripamil Nasal Spray for Patients with Paroxysmal Supraventricular Tachycardia Open, multicenter and multinational study on the safety of etripamil nasal spray for patients with
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: MILESTONE PHARMACEUTICALS, INC.
- Phase: III
- Execution start: 05/03/2020
- End of execution: 31/08/2021
- IP: LUIS TERCEDOR SANCHEZ
